Capital World Investors »

Generate Biomedicines Ord shares owned by Capital World Investors

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Capital World Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $50M 4.0M 12.50

More positions owned by Capital World Investors

Broadcom (AVGO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Amgen (AMGN)
Canadian Natural Resources (CNQ)

View all positions for Capital World Investors

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
Capital World Investors
Braidwell
Arch Venture Corp
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Morgan Stanley
ExodusPoint Capital Management
CenterBook Partners
Sphera Funds Management

View all funds holding Generate Biomedicines Ord